Streetbeat News

Products Services

AMZN

DIS

NFLX

PARA

WBD

Amazon Prime Video plans to increase advertisements in 2025, following Netflix and Disney+'s strategies. Amazon aims to boost its ad revenue, which rose 20% to $12.8 billion in Q2 2024. The company targets 19 million monthly British viewers and explores interactive ad formats.

Portfolio Pulse from Anusuya Lahiri

October 03, 2024 | 12:02 pm

T

TMUS

VZ

European telecom companies, including Vodafone, Telefonica, and Orange, are considering legal action against SpaceX's Starlink if the FCC relaxes radio emission rules. They argue that such changes could harm terrestrial mobile networks. U.S. companies like AT&T and Verizon also express concerns. SpaceX seeks a waiver to ensure reliable communications, especially during emergencies, and has reached a milestone with its 7,000th satellite launch.

Portfolio Pulse from Rounak Jain

October 03, 2024 | 11:50 am

ZKIN

ZK International has secured a $4.47 million contract with Shenzhen Gas Group for a gas pipeline project in Shenzhen, involving the supply of advanced crimped carbon steel pipes and fittings for residential buildings.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:46 am

PIRS

Palvella Therapeutics, the merger partner of Pieris Pharmaceuticals, has received a grant of up to $2.6 million from the FDA's Office of Orphan Products Development. This grant will support the Phase 3 SELVA trial of QTORIN 3.9% Rapamycin Anhydrous Gel for treating Microcystic Lymphatic Malformations.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:42 am

ELAB

Elevai Labs' stock is declining following the announcement that its subsidiary, Elevai Biosciences, has filed two patent applications for EL-22, a treatment for muscle loss in obese patients.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:41 am

LEVI

Levi Strauss & Co shares declined following disappointing Q3 sales results and a FY24 adjusted EPS guidance midpoint below estimates. The company is reviewing strategic options for its Dockers brand, including a potential sale.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:39 am

ELAB

Elevai Labs has filed two patent applications for its lead candidate, EL-22, targeting muscle loss treatment in obese patients. The patents cover standalone and combination therapies with GLP-1 receptor agonists.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:38 am

BBIO

BridgeBio Pharma will present 42-month outcomes data from its Phase 2 ATTRibute-CM study at the American Heart Association Scientific Sessions. This data is from an ongoing long-term open-label extension study.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:37 am

SNGX

Soligenix has partnered with Sterling Pharma Solutions to optimize and implement scalable production technology for synthetic hypericin. The collaboration aims to transfer and optimize manufacturing processes for GMP manufacturing, targeting clinical trials and long-term commercial production.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:37 am

GDTC

CytoMed Therapeutics has acquired the license and assets of Cellsafe International, a Malaysian cord blood bank. This acquisition includes a cord blood banking license, cryopreservation equipment, and real estate, enhancing CytoMed's cell therapy strategy.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 11:34 am